Active Pharmaceutical Ingredients (API)

Aesica has been engaged in the manufacture of generic APIs for over 30 years and, combined with our development and supply services, we have the facilities and expertise to take an API from pre-clinical all the way to commercial scale manufacture.

Clinical Supply

We’re a global leader in API generic manufacture in areas such as non-steroidal anti-inflammatory (NSAID’s) products, antidepressants and anaesthetics, and all our generic APIs are manufactured according to cGMP and appropriate regulatory frameworks (MHRA, FDA, PDMA, CEP, etc.). Our focus on operational excellence and continuous improvement ensures our processes are efficient and effective.

As part of our complete end-to-end API generic manufacture solution, we offer a systematic, tried and tested approach to technology transfer overseen every step of the way by our dedicated project managers and experienced technical teams.


How Aesica can add value at every stage

Finished dose development – Finished dose manufacture – API development